Predictive value of HbA1c for in-hospital adverse prognosis in COVID-19: a systematic review and meta-analysis
Clinical and laboratory predictors of adverse clinical course and death in COVID-19 patients urgently need to be identified. So far, the association between HbA1c and in-hospital mortality of COVID-19 remains a controversial issue. The aim of this study is to analyze predictive value of HbA1c for adverse prognosis in COVID-19.
Source: Primary Care Diabetes - Category: Primary Care Authors: Zheng Zhu, Yaqian Mao, Gang Chen Source Type: research
More News: COVID-19 | Diabetes | Endocrinology | Hospitals | Laboratory Medicine | Primary Care | Study